22:09 , Oct 26, 2018 |  BioCentury  |  Finance

Synthego scales up

In light of growing demand for its CRISPR-based products, Synthego Corp. raised a $110 million series C round to ramp up commercialization of existing products and broaden its portfolio. Founders Fund led the round, which...
19:41 , Oct 26, 2018 |  BC Week In Review  |  Financial News

Synthego raises $110M series C to scale up CRISPR research products

Synthego Corp. (Redwood City, Calif.) raised a $110 million series C round to grow its CRISPR-based product line for researchers. Founders Fund led the round, which was also backed by fellow existing investors 8VC and...
11:01 , Oct 23, 2018 |  BC Extra  |  Financial News

Synthego raises $110M series C to scale up CRISPR research products

Synthego Corp. (Redwood City, Calif.) raised a $110 million series C round to grow its CRISPR-based product line for researchers. Founders Fund led the round, which was also backed by fellow existing investors 8VC and...
17:40 , Sep 28, 2018 |  BC Week In Review  |  Financial News

AI diagnostic company IDx raises $33M venture round

AI diagnostic company IDx LLC (Coralville, Iowa) raised $33 million in a venture financing on Sept. 26 led by 8VC, with participation from Optum Ventures, Alpha Edison and Heritage Provider Network. In April, FDA approved...
21:00 , Sep 21, 2018 |  BioCentury  |  Finance

A bigger ‘biome

With direct-to-consumer products and diagnostics on the market, uBiome Inc. has raised an $83 million series C round to leverage its growing microbiome database and build a therapeutics pipeline. OS Fund led the round, which...
17:38 , Sep 21, 2018 |  BC Week In Review  |  Financial News

uBiome moving into therapeutics with $83M series C

Microbiome tech and diagnostic company uBiome Inc. (San Francisco, Calif.) raised $83 million in a series C round led by OS Fund to expand into drug research and development using its patented microbiome assets. Also...
11:00 , Sep 21, 2018 |  BC Extra  |  Financial News

uBiome moving into therapeutics with $83M series C

Microbiome tech and diagnostic company uBiome Inc. (San Francisco, Calif.) raised $83 million in a series C round led by OS Fund to expand into drug research and development using its patented microbiome assets. Also...
17:19 , Aug 3, 2018 |  BC Week In Review  |  Financial News

CRISPR diagnostics play Mammoth raises $23M series A

Mammoth Biosciences (San Francisco, Calif.) raised $23 million on July 31 in a series A round led by Mayfield Partners, with participation from fellow seed investors NFX and 8VC. Co-founder and CEO Trevor Martin told...
16:03 , Jul 31, 2018 |  BC Extra  |  Financial News

CRISPR diagnostics play Mammoth raises $23M series A

Mammoth Biosciences (San Francisco, Calif.) raised $23 million in a series A round led by Mayfield Partners, with participation from fellow seed investors NFX and 8VC. Co-founder and CEO Trevor Martin told BioCentury the funds...
19:51 , Apr 27, 2018 |  BC Week In Review  |  Company News

Mammoth emerges to bring CRISPR into diagnostic space

Mammoth Biosciences (San Francisco, Calif.) debuted on April 26 with a CRISPR-based diagnostic platform and an exclusive license to IP covering work from CRISPR pioneer Jennifer Doudna. While CRISPR-based therapeutics have garnered the most attention...